Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Erickson

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Journal of Virology|March 1, 1994
Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitorD D Ho, T Toyoshima, H Mo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral proteaseA H Kaplan, S F Michael, R S Wehbie, et al.
Biochemistry|December 23, 1998
Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?E M Towler, S V Gulnik, T N Bhat, et al.
Journal of Medicinal Chemistry|May 30, 1998
Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitorsS F Martin, G O Dorsey, T Gane, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparumA M Silva, A Y Lee, S V Gulnik, et al.
Bioorganic & Medicinal Chemistry|September 1, 1996
Discovery and optimization of nonpeptide HIV-1 protease inhibitorsP J Tummino, J V Prasad, D Ferguson, et al.
Journal of Medicinal Chemistry|November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV proteaseB D Tait, S Hagen, J Domagala, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Journal of Virology|March 1, 1994
Characterization of human immunodeficiency virus type 1 variants with increased resistance to a C2-symmetric protease inhibitorD D Ho, T Toyoshima, H Mo, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 7, 1994
Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral proteaseA H Kaplan, S F Michael, R S Wehbie, et al.
Biochemistry|December 23, 1998
Functional characterization of the protease of human endogenous retrovirus, K10: can it complement HIV-1 protease?E M Towler, S V Gulnik, T N Bhat, et al.
Journal of Medicinal Chemistry|May 30, 1998
Cyclopropane-derived peptidomimetics. Design, synthesis, evaluation, and structure of novel HIV-1 protease inhibitorsS F Martin, G O Dorsey, T Gane, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparumA M Silva, A Y Lee, S V Gulnik, et al.
Bioorganic & Medicinal Chemistry|September 1, 1996
Discovery and optimization of nonpeptide HIV-1 protease inhibitorsP J Tummino, J V Prasad, D Ferguson, et al.
Journal of Medicinal Chemistry|November 26, 1997
4-hydroxy-5,6-dihydropyrones. 2. Potent non-peptide inhibitors of HIV proteaseB D Tait, S Hagen, J Domagala, et al.
Bioorganic & Medicinal Chemistry|February 5, 2000
Nonpeptidic HIV protease inhibitors possessing excellent antiviral activities and therapeutic indices. PD 178390: a lead HIV protease inhibitorJ V Prasad, F E Boyer, J M Domagala, et al.
Pageof 10